Journal article icon

Journal article

Bortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms? Does bortezomib inform our understanding of the immunology underlying neuromyelitis optica spectrum disorders?

Subtitle:
Comment
Publication status:
Published
Peer review status:
Reviewed (other)

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Clinical Neurosciences
Oxford college:
St Hildas College
Role:
Author
Fulbright Commission More from this funder
Publisher:
American Medical Association) Publisher's website
Journal:
JAMA Neurology Journal website
Volume:
75
Issue:
1
Pages:
128-129
Publication date:
2017-11-20
Acceptance date:
2017-09-29
DOI:
EISSN:
2168-6157
ISSN:
2168-6149
Pubs id:
pubs:735437
URN:
uri:6a007323-8a45-4e07-a22b-a67a8f4d28aa
UUID:
uuid:6a007323-8a45-4e07-a22b-a67a8f4d28aa
Local pid:
pubs:735437

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP